Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013

In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and...

Full description

Bibliographic Details
Main Authors: Kadidja Gamougam, Doumagoum M. Daugla, Jacques Toralta, Cyriaque Ngadoua, Florence Fermon, Anne-Laure Page, Mamoudou Djingarey, Dominique A. Caugant, Olivier Manigart, Caroline L. Trotter, James M. Stuart, Brian M. Greenwood
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2015-01-01
Series:Emerging Infectious Diseases
Subjects:
meningitis
meningococcal
serogroup A
vaccine
Africa
bacteria
Online Access:https://wwwnc.cdc.gov/eid/article/21/1/14-0256_article

Internet

https://wwwnc.cdc.gov/eid/article/21/1/14-0256_article

Similar Items